Kimberly-Clark Corporation (NASDAQ:KMB) is not usually the first name that comes up when investors discuss Dividend Kings. Its track record says it probably should be. The consumer staples company has increased its dividend for 54 consecutive years and has paid dividends for 92 years. For income investors, that kind of consistency is difficult to dismiss.
In January 2026, Kimberly-Clark raised its quarterly dividend from $1.26 to $1.28 per share, taking the annual payout to $5.12 per share. With the stock trading near $110, that works out to a yield of about 4.6%. The yield stands out even more when paired with a dividend that has been growing for more than five decades.
Image by Steve Buissinne from Pixabay
Much of Kimberly-Clark Corporation (NASDAQ:KMB)'s appeal comes from what it sells. Its products are not things people buy only when the economy is doing well. Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise and Depend are familiar names, and the company says its brands hold No. 1 or No. 2 positions in roughly 70 countries.
That gives the company a fairly dependable source of demand. When money gets tight, consumers may postpone larger or less essential purchases, but diapers, tissues, toilet paper, and personal-care products still have to be bought. This helps Kimberly-Clark keep its revenue and cash flow steadier than companies that rely more heavily on discretionary spending.
The downside is that the dividend is not growing very quickly. Its five-year annualized growth rate is around 3%, which means investors are unlikely to see large increases each year. Still, the company has continued to raise the payout through inflation, weaker consumer spending, and periods of margin pressure. For some income investors, that reliability matters more than fast dividend growth.
The 54-year streak is impressive, but a long history alone does not pay the dividend. Kimberly-Clark Corporation (NASDAQ:KMB) also needs to keep producing enough cash to fund the payout and invest in the business at the same time.
The numbers from the first half of 2026 were encouraging. Cash from operations, including discontinued operations, came in at $1.7 billion, up from $1.1 billion a year earlier. Capital spending also increased, reaching $776 million versus $401 million previously. At the same time, Kimberly-Clark paid $843 million in dividends to shareholders.
Management is expecting about $2 billion in adjusted free cash flow for 2026, which would be roughly in line with 2025. That is despite plans to spend about $1.3 billion on capital investments. That is important because the dividend ultimately depends on cash generation. With solid free cash flow, Kimberly-Clark Corporation (NASDAQ:KMB) can continue paying shareholders while putting money into the business and managing its balance sheet.
The Kenvue acquisition could be where the story gets more interesting. The deal would expand Kimberly-Clark Corporation (NASDAQ:KMB)'s presence in health and wellness and give it a larger portfolio of products to work with. More importantly, it could provide a new source of growth at a company where dividend growth has been fairly modest.
Management expects the transaction to add about $1.9 billion in cost synergies and another $500 million in profit from revenue synergies within three to four years of closing. If those targets are achieved, the deal could make a meaningful difference to Kimberly-Clark's earnings. Getting there, though, will take time and investment.
The deal is not without its risks. Kenvue has been dealing with inflation, tariffs, and currency headwinds, and Kimberly-Clark will have to absorb a large acquisition. The transaction is expected to close in the fourth quarter of 2026, which means investors will not see the full benefits right away. Execution will matter a lot.
If the integration goes well, Kimberly-Clark Corporation (NASDAQ:KMB) could come out of the deal with a broader health and personal-care business and better growth prospects. Higher earnings and stronger cash flow would also give the company more flexibility when it comes to future dividend increases.
Kimberly-Clark's dividend record has never been about spectacular growth. The company has built it the slower way: selling everyday products, generating cash and steadily returning part of that cash to shareholders through different economic cycles.
The roughly 4.6% yield is a big part of the investment case. The dividend is growing slowly, so investors should keep their expectations in check on future increases. But starting with a higher yield can make even modest raises worthwhile for someone whose main goal is income.
Kenvue makes the outlook less straightforward, but it also gives Kimberly-Clark Corporation (NASDAQ:KMB) an opportunity to change its growth trajectory. There will be financial and execution risks during the integration. If management gets the deal right, stronger earnings and cash flow could eventually give shareholders more upside.
For investors who put dependable income ahead of rapid growth, Kimberly-Clark remains worth considering. The dividend may only be growing at a modest pace, but the 54-year streak, everyday product portfolio, and cash generation give the stock a solid foundation. Kenvue raises the level of risk, but it could also be the change Kimberly-Clark needs to improve growth. If management delivers on its synergy targets and turns the acquisition into stronger cash flow, the stock could become more attractive to long-term income investors.
While we acknowledge the potential of KMB as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: Medtronic plc (MDT) is Closing in on Dividend King Status and PepsiCo (PEP)'s Dividend is Strong but the Stock Needs a Turnaround
Disclosure: None. This article is originally published at Insider Monkey.